Alprazolam-Induced Hypomania

  title={Alprazolam-Induced Hypomania},
  author={Janardhan Y. C. Reddy and Sumant Khanna and Udit Anand and Aniketa Banerjee},
  journal={Australian and New Zealand Journal of Psychiatry},
  pages={550 - 552}
Objective: There are reports of alprazolam-induced hypomania/mania. Here is a case report of a patient who developed hypomania during treatment with alprazolam, but not with diazepam, another benzodiazepine derivative. Clinical picture: The illness was of 2 months' duration and the patient received a diagnosis of anxious depression. Following treatment with alprazolam, the patient developed hypomania characterised by euphoria, overactivity, overtalkativity, racing thoughts, oversocialisation… 

Hypnotics and sedatives

A Comprehensive Review of the Analytical Development and Validation of Alprazolam in Bulk and Pharmaceutical Dosage Form

Alprazolam is approved in 2003 by US FDA. Alprazolam is available as an extended-release tablet, a mouth dissolving tablet (a tablet that dissolves rapidly in the mouth), as well as a concentrated

Alcohol withdrawal delirium manifested by manic symptoms in an elderly patient

  • H. ChanKuan-I Lee
  • Medicine, Psychology
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
  • 2015
A case involving a 63‐year‐old man who had alcohol withdrawal delirium that was manifested mainly by manic symptoms is reported, which is associated with significant morbidity and mortality.

Alprazolam Kullanımına Bağlı Anksiyete Artışı

Anksiyete bozukluklari toplumda en yaygin gorulen, sosyal, mesleki ya da diger gunluk islevlerde kayiplara yol acan ruhsal bozukluklardir. Anksiyete semptomlarinin azaltilmasi amaciyla yaygin olarak

Bipolar disorder in women: reproductive events and treatment considerations

The main objectives are to assess the impact of reproductive events on the course of the disorder, and to discuss the relationships between reproductive events and psychiatric treatments.



Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

Alprazolam was found to be effective and well tolerated in patients with agoraphobia with panic attacks and panic disorder and significantly more placebo recipients subsequently dropped out of the trial, primarily citing ineffectiveness of placebo as the reason.

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.

Treatment-related side effects that were worse in patients taking alprazolam than in those taking placebo included sedation, fatigue, ataxia, slurred speech, and amnesia, which tended to subside with dose reduction or continued administration of the drug.

A case of alprazolam, but not lorazepam, inducing manic symptoms.

A patient developed manic symptoms during treatment with alprazolam, and subsequent administration of an equivalent dosage of lorazepam did not induce manic symptoms, suggesting the possibility of a novel benzodiazepine mechanism of action.

Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines.

  • J. ColeJ. Kando
  • Psychology, Medicine
    The Journal of clinical psychiatry
  • 1993
It appears that some differences between alprazolam and older benzodiazepines may exist, and worsening in post-traumatic stress disorder and an increase in impulsive behavior in patients with borderline personality disorder have only been reported in patients receiving alpazolam.

Buspirone vs Alprazolam: A Double-Blind Comparative Study of Their Efficacy, Adverse Effects and Withdrawal Symptoms

Results of this study indicate a superiority of buspirone over alprazolam with regard to adverse effects and withdrawal symptoms.

Drug Treatment of Panic Disorder: Comparative Efficacy of Alprazolam, Imipramine, and Placebo

  • G. Klerman
  • Psychology, Medicine
    British Journal of Psychiatry
  • 1992
The Cross-National Collaborative Panic Study, Phase Two, compared alprazolam with imipramine and with placebo in a sample of 1168 randomly assigned subjects, and both were superior to placebo for most outcome measures.

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.

Alprazolam therapy was effective and well tolerated at a mean daily dose of 5.7 mg and Imipramine hydrochloride (175 mg/d) also produced significant panic relief but was associated with poor patient acceptance.

Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.

  • J. Cohn
  • Psychology, Medicine
    The Journal of clinical psychiatry
  • 1981
Both alprazolam and diazepam were superior to placebo for the treatment of the clinical anxiety syndrome throughout a four-week double-blind multiclinic trial in 976 outpatients. At the fourth-week

Drug treatment of panic disorder : comparative efficacy of alpra - zolarn . imipramine , and placebo

  • British Journal of Psychiatry
  • 1992